Press centre News Коммерческая практика

5
October
2016

The authorities are demanding that companies reduce prices for expensive drugs

The government intends to significantly reduce the huge prices charged vital medicines. Officials have begun negotiations with pharmaceutical companies that produce drugs for the treatment of HIV, cancer and haemophilia.

RBC
9
September
2016

Soaring indignation. Roszdravnadzor carries out large-scale testing of drugs

The Territorial Departments of the Federal Service for Supervision in the Sphere of Health sent to distributors and drugstore chains demands to provide samples of medicinal products, as well as documents confirming their quality. Some Territorial Departments attached a list containing 330 drug names. By all indications, it seems that this list was intended only for internal use by the Territorial Departments, and after getting to the outside world, has created quite a commotion. For example, some market participants suggested that the agency wanted to get all 330 named medicines from them. They were especially impressed with the demand to provide 876 packets of Levitra.

Pharmaceutical Bulletin
3
August
2016

The Ministry of Economic Development is proposing to extend Law 44-FZ to purchases by funds and autonomous institutions

The Ministry of Economic Development is proposing to extend Law 44-FZ, On the Contract System, to purchases by funds and autonomous institutions that are paid for out of public funds. The draft law can be viewed at regulation.gov.ru.

Information portal "Torg umesten"
14
July
2016

Senators approved the scandalous amendments to the law “On Trade”

According to Vedomosti, in favour of the adoption of amendments to the law voted 132 senators, although some had opposed certain provisions of the law.

Arendator.ru
17
May
2016

The third was a complete fool

Distributors are faced with new problems in the application of the “odd man out” regulation. They are subject to penalties, if their applications are rejected because of this document more than two times during one quarter. According to FV, wholesalers are so unhappy with the situation, that they have already applied to the Ministry of Economic Development. The ministry has confirmed that this problem is well known to them, and that they have taken a number of steps to address this issue.

Pharmaceutical Bulletin
12
April
2016

Spy bridge

“FV” analysed the draft amendments to Law FZ-7 “On Non-Profit Organizations” within the sphere of clarifying the notion of “political activities”, and came up with a curious conclusion. If this law is adopted, joining the ranks of foreign agents, with a high degree of probability, will be the majority of charities and professional associations operating in the pharmaceutical industry. Moreover, these may not only be the companies, whose staff is composed of citizens of other countries, but also those whose members are traditionally domestic organizations, but with offshore charter capital.

Pharmaceutical Bulletin
22
March
2016

Experts: greater control over public procurement is not a panacea for corruption

During the spring session, the State Duma will review three draft bills that should transition state procurement processes into electronic auctions, as well as minimize cases where goods are acquired from a single supplier, and the possibility of failure to conclude a contract after a supplier has been chosen. These draft bills were met with resistance on the part of major state-owned companies. Experts are also ambivalent about the possible adoption of these bills – the transition to electronic trading on the background of an economic crisis and a budget deficit, can hardly be considered a panacea.

Pravo.ru
18
February
2016

Merry starts

Federal State Institution “State Institute of Drugs and Good Practices” officially started its work, at the request of foreign companies, on carrying out inspections

Pharmaceutical Bulletin
3
October
2016

Las week’s news – in one line

Alcohol advertising could return to print and the Internet

Shopolog.ru
11
August
2016

The draft law on state procurement for the provision of social services will affect the pharmaceutical market

Russia’s Finance Ministry has developed a draft law “On State (Municipal) Orders for the Provision of Public (Municipal) Social Services and Amendments to Certain Legislative Acts of the Russian Federation”. These services the citizens will be able to receive in the areas of education, social protection, employment, health, etc.

Pharmaceutical Bulletin
19
July
2016

Rejuvenating operations

The FAS explained how pharmacies and wholesalers need to operate in the case of cancellation of registered drug prices

Pharmaceutical Bulletin
20
June
2016

FAS Russia has explained the term “advertiser”

FAS Russia has specified who exactly should be considered an advertiser.

Pharmaceutical Bulletin
21
April
2016

FAS fines Perekrestok for exchanging discount cards with Azbuka Vkusa

Moscow Office of FAS has fined the Perekrestok supermarket chain for offering buyers, who would give up their discount cards from a competing supermarket chain, bonus points, according to the competition authority’s press service.

Pravo.ru
8
April
2016

"... For two weeks, the Bank has not been crediting money, without giving any reasons for this. What to do?"

In the company, in which our reader works, arose a conflict with the bank. The buyer paid for the goods, but the company has not received the money. The bank believes that it has the right to keep this money on their correspondent account for 40 days, without explaining the reasons for this. The bankers and independent experts discuss if this is legal.

Сollective of authors, VEGAS LEX
Accounting. Taxes. Law
10
March
2016

Pride and Prejudice

FAS Russia considered the behaviour of the Ministry of Health of the Russian Federation as not meeting the requirements of the Law “On Protection of Competition” and issued a warning to the agency to eliminate these violations. According to the FAS, the Ministry of Health is too zealous when it comes to making changes in the state register of maximum permissible selling prices, thereby preventing adequate work of pharmaceutical companies.

Pharmaceutical Bulletin
29
January
2016

Silent “MAX”

How a reputable insurer lost its voice in a loud health project

Vademecum
Pages: Prev. 1 2 3 4 Next

Apply to participate

Agreement

Apply to participate

Оценка:

Agreement